Janani Rangaswami1,2, Mario Naranjo1, Peter A McCullough3. 1. Department of Medicine, Division of Nephrology, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA. 2. Sidney Kimmel College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA. 3. Baylor University Medical Center, Baylor Heart and Vascular Institute, Dallas, Texas, USA.
Abstract
BACKGROUND: Preeclampsia is a multisystem vascular disorder of pregnancy that remains a leading cause of maternal and fetal morbidity and mortality. Preeclampsia remains an underrecognized risk factor for future cardiovascular and kidney disease in women and represents the confluence of preexisting vascular risk factors with superimposed endothelial injury from placental mediated anti-angiogenic factors. SUMMARY: This review highlights the close relationship between preeclampsia and future cardiovascular and kidney disease. It describes the pathophysiology and current understanding of biomarkers that form the molecular signature for long-term endothelial dysfunction in preeclamptic women. Finally, it describes strategies for early identification and management of women with preeclampsia with elevated risk for cardiovascular and kidney disease. Key Messages: Future rigorous studies on cardiovascular risk modification in this phenotype of disease are essential to reduce the burden of cardiovascular and kidney disease, in women with preeclampsia.
BACKGROUND: Preeclampsia is a multisystem vascular disorder of pregnancy that remains a leading cause of maternal and fetal morbidity and mortality. Preeclampsia remains an underrecognized risk factor for future cardiovascular and kidney disease in women and represents the confluence of preexisting vascular risk factors with superimposed endothelial injury from placental mediated anti-angiogenic factors. SUMMARY: This review highlights the close relationship between preeclampsia and future cardiovascular and kidney disease. It describes the pathophysiology and current understanding of biomarkers that form the molecular signature for long-term endothelial dysfunction in preeclamptic women. Finally, it describes strategies for early identification and management of women with preeclampsia with elevated risk for cardiovascular and kidney disease. Key Messages: Future rigorous studies on cardiovascular risk modification in this phenotype of disease are essential to reduce the burden of cardiovascular and kidney disease, in women with preeclampsia.
Authors: Tejas V Patel; Jeffrey A Morgan; George D Demetri; Suzanne George; Robert G Maki; Michael Quigley; Benjamin D Humphreys Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506
Authors: Giovana S Di Marco; Stefan Reuter; Uta Hillebrand; Susanne Amler; Maximilian König; Etienne Larger; Hans Oberleithner; Eva Brand; Hermann Pavenstädt; Marcus Brand Journal: J Am Soc Nephrol Date: 2009-07-16 Impact factor: 10.121
Authors: Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi Journal: J Clin Invest Date: 2003-03 Impact factor: 14.808
Authors: Shiliang Liu; K S Joseph; Wei Luo; Juan Andrés León; Sarka Lisonkova; Michiel Van den Hof; Jane Evans; Ken Lim; Julian Little; Reg Sauve; Michael S Kramer Journal: Circulation Date: 2016-08-30 Impact factor: 29.690
Authors: Dalia Yousif; Ioannis Bellos; Ana Isabel Penzlin; Mido Max Hijazi; Ben Min-Woo Illigens; Alexandra Pinter; Timo Siepmann Journal: Front Neurol Date: 2019-08-06 Impact factor: 4.003
Authors: Peter M Barrett; Fergus P McCarthy; Karolina Kublickiene; Marie Evans; Sarah Cormican; Conor Judge; Ivan J Perry; Marius Kublickas; Peter Stenvinkel; Ali S Khashan Journal: BMJ Open Date: 2019-05-05 Impact factor: 2.692